Funding
- Grant: #U01DA050330
- Principal Investigator: Norman, Andrew
- Dates: 09-15-2019 -07-31-2022
- Funding Agency: National Institute on Drug Abuse
- Title: IND-Enabling Pre-Clinical Studies to Accelerate the Clinical Development of a Humanized Anti-Cocaine Monoclonal Antibody Role
- Total Project Funding: $1,796,316.00
- Status: Avtive
- Grant: #U01DA048525
- Principal Investigator: Norman, Andrew
- Dates: 07-01-2019 -04-30-2022
- Funding Agency: National Institute on Drug Abuse
- Title: First-In-Human Study of a Humanized Anti-Cocaine Monoclonal Antibody Role
- Total Project Funding: $4,770,702.00
- Status: Active
- Grant: #U01DA039550
- Principal Investigator: Norman, Andrew
- Dates: 08-01-2015 - 05-31-2018
- Funding Agency: National Institutes of Health
- Title: Advancing the Development of a Humanized Anti-cocaine Monoclonal Antibody
- Total Project Funding: $6,259,187.00
- Status: Active
- Grant: #DP1 DA031386
- Principal Investigator: Norman, Andrew
- Dates: 09-30-2010 - 07-31-2015
- Funding Agency: National Institute on Drug Abuse
- Title: A Human Antibody as an Immunotherapy for Cocaine Abuse (DP1)
- Total Project Funding: $3,800,342.00
- Status: Completed
- Grant: #P2D R43 DA023294
- Subcontract Principal Investigator: Norman, Andrew
- Dates: 04-01-2007 - 03-31-2008
- Funding Agency: National Institute on Drug Abuse
- Title: Cocaine Therapeutic: PD2007DA Transport Inhibitor
- Total Project Funding $57,085.00
- Status: Competed
- Grant: #44DA018538
- Principal Investigator: Norman, Andrew
- Dates: 09-01-2004 - 12-31-2009
- Funding Agency: National Institute On Drug Abuse
- Title: A human antibody as an immunotherapy for cocaine abuse
- Total Project Funding: $2,975,367.00
- Status: Completed
- Grant: #5-U19-DA-12043-05-A0-S0-E0
- Principal Investigator: Norman, Andrew
- Dates: 09-01-1998 - 12-31-2004
- Funding Agency: National Institute on Drug Abuse
- Title: Passive Immunity to Cocaine Using Novel Human Antibodies
- Total Project Funding: $4,862,093.00
- Status: Completed
Intranet Login
Contact Us
Department of Pharmacology, Physiology,
and Neurobiology
College of Medicine
PO Box 670576
Cincinnati, OH 45267-0576
Ms. Jennifer Bedel
Associate To The Chair
Phone: 513-558-5636
Email: bedelj@ucmail.uc.edu